Abstract

The regulation of the dopamine transporter (DAT) impacts extracellular dopamine levels after release from dopaminergic neurons. Furthermore, a variety of protein partners have been identified that can interact with and modulate DAT function. In this study we show that DJ-1 can potentially modulate DAT function. Co-expression of DAT and DJ-1 in HEK-293T cells leads to an increase in [3H] dopamine uptake that does not appear to be mediated by increased total DAT expression but rather through an increase in DAT cell surface localization. In addition, through a series of GST affinity purifications and co-immunoprecipitations, we provide evidence that the DAT can be found in a complex with DJ-1, which involve distinct regions within both DAT and DJ-1. Using in vitro binding experiments we also show that this complex can be formed in part by a direct interaction between DAT and DJ-1. Co-expression of a mini-gene that can disrupt the DAT/DJ-1 complex appears to block the increase in [3H] dopamine uptake by DJ-1. Mutations in DJ-1 have been linked to familial forms of Parkinson’s disease, yet the normal physiological function of DJ-1 remains unclear. Our study suggests that DJ-1 may also play a role in regulating dopamine levels by modifying DAT activity.

Highlights

  • Dopaminergic neurotransmission is mediated by volume transmission that is largely extrasynaptic and is regulated by the levels of dopamine (DA) in the extracellular space [1,2,3,4,5,6,7,8]

  • Studies have shown that DJ-1 can interact with a wide variety of proteins including apoptosis signal-regulating kinase 1 [87], Hsp70 [88], α-synuclein [84,89,90,91], Daxx [78], MEKK1 [92], DJBP [76], HIPK1 [79], Topors/ p53BP3 [93], PIASxα [94] and TTRAP [95]

  • DJ-1 is expressed in the terminals of DA neurons [96] and DJ-1 null mice appear to exhibit increased DA reuptake [54,56] while exhibiting decreased D2 autoreceptor function [54,57], two key elements in regulating DA levels, which corresponds to increased DA tissue content in mice lacking DJ-1

Read more

Summary

Introduction

Dopaminergic neurotransmission is mediated by volume transmission that is largely extrasynaptic and is regulated by the levels of dopamine (DA) in the extracellular space [1,2,3,4,5,6,7,8]. One of the major mechanisms for regulating DA levels is through reuptake via the dopamine transporter (DAT). In addition to DA, the DAT facilitates the reuptake of the neurotoxin 1-methy-4-phenylpyridinium (MPP+), which induces symptoms resembling Parkinson’s disease (PD) [9,10,11,12]. DAT regulation can be mediated by various means including activation of PKC [17,18,19,20,21,22], PKA [22,23,24,25], CaMKII [25,26,27,28] and tyrosine kinase [29,30,31,32]. DAT endocytosis has been demonstrated to occur by ubiquitination

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.